Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10683959)

  • 21. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of human choriocarcinoma cell line derived from a metastatic focus of a testicular mixed germ cell tumor.
    Ishiwata I; Ishiwata C; Soma M; Ono I; Nakaguchi T; Kiguchi K; Furusato M; Tachibana T; Hashimoto H; Ishikawa H
    Hum Cell; 1999 Dec; 12(4):219-27. PubMed ID: 10834109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.
    Ulbright TM; Orazi A; de Riese W; de Riese C; Messemer JE; Foster RS; Donohue JP; Eble JN
    Mod Pathol; 1994 Jan; 7(1):64-8. PubMed ID: 7909155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikreins expression in a mature cystic ovarian teratoma.
    Tremblay RR; Deperthes D; Mailloux J; Lemay M; Dubé JY
    J Clin Lab Anal; 1996; 10(4):229-31. PubMed ID: 8811467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M; Birner P; Breitenecker G; Oberhuber G
    Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
    Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
    Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical analysis of juvenile ovary granulose cell tumor].
    Huang JN; Liu YZ; Zhang XM
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):533-6. PubMed ID: 17983492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
    Shen XX; Yu L; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
    Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
    Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor GATA-6 is expressed in malignant endoderm of pediatric yolk sac tumors and in teratomas.
    Siltanen S; Heikkilä P; Bielinska M; Wilson DB; Heikinheimo M
    Pediatr Res; 2003 Oct; 54(4):542-6. PubMed ID: 12867597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of two-tier grading system and significance of p53 protein over-expression in ovarian serous carcinoma].
    Lin J; Du J; Zhang CY; Xie QT; Zhang B; Liu CR
    Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):655-60. PubMed ID: 21176529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
    Ulbright TM
    Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term follow-up of the ovarian malignant teratoma].
    Zhu GZ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):220-3, 253-4. PubMed ID: 8404306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.